SCHEMBL26818366

SCHEMBL26818366

CSCCC(NC(=O)C(NC(=O)C(NC(=O)C(N)CS)C(C)C)C(C)C)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FNTA P49354 18/20 0.68
FNTB P49356 18/20 0.68
PGGT1B P53609 7/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13138431 1.00 FNTA (0.68) FNTAFNTBPGGT1B
SCHEMBL34473997 0.91 FNTA (0.58) FNTAFNTBPGGT1B
SCHEMBL30051582 0.91 FNTA (0.58) FNTAFNTBPGGT1B
SCHEMBL27799999 0.91 FNTA (0.67) FNTAFNTBPGGT1B
SCHEMBL2543348 0.91 FNTA (0.67) FNTAFNTBPGGT1B
SCHEMBL29359191 0.88 FNTA (0.64) FNTAFNTBPGGT1B
SCHEMBL26818348 0.88 FNTA (0.69) FNTAFNTBPGGT1B
SCHEMBL8519036 0.87 FNTA (0.78) FNTAFNTBPGGT1B
SCHEMBL12519269 0.87 FNTA (0.78) FNTAFNTBPGGT1B
SCHEMBL8519753 0.87 FNTA (0.62) FNTAFNTBPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING Changzhou University (CN) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING PTMS, CBS, CHAMP1 FNTA 1663/4885FNTB 770/4885PGGT1B 4274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.